Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's revenue for the
six
months ended in Dec. 2024 was R$7.23 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2024 was R$7.23 Mil.
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's Revenue per Share for the
six
months ended in Dec. 2024 was R$8.49.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was R$8.49.
Warning Sign:
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba revenue per share has been in decline over the past 3 years.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Revenue Related Terms
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Revenue Chart
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Revenue vs REITs Industry
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
For stock reported annually, GuruFocus uses latest annual data as the TTM data. Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was R$7.23 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11) has a Revenue of R$7.23 Mil as of Dec. 2024. Revenue is the total amount a company generates as sales through its operations. View historical data on Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba and its competitors.
Is Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's Revenue too high?
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's current Revenue is R$7.23 Mil. Overall, Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's Revenue compare to WELL and VTR?
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's Revenue of R$7.23 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a REITs company?
A good Revenue depends on the REITs industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba and its competitors. Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's current Revenue is R$7.23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba stock overvalued right now?
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11) has a current Revenue of R$7.23 Mil. The stock's GF Value™ is R$33.29, compared to a current price of R$96.01 — trading 188.4% above its estimated fair value. The current Revenue is R$7.23 Mil. Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11), the current Revenue is R$7.23 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11) Overvalued in 2026?
Based on GuruFocus' analysis, Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba stock appears to be overvalued.
The current stock price of R$96.01 is trading 188.4% above its estimated GF Value™ of R$33.29.
Key valuation signals for BSP:HUSC11:
Revenue: R$7.23 Mil
GF Value™: R$33.29 vs. price of R$96.01 (188.4% above fair value)
No single metric tells the full story. See the BSP:HUSC11 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:HUSC11 has been successfully added to your 
